August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
The Watchman device is designed to keep harmful sized blood clots that form in the left atrial appendage from ...
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now